NCT01522950View on ClinicalTrials.gov

A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function

PHASE2CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Hypertension

Interventions

DRUG

Nebivolol

5 mg daily or 10 mg daily

DRUG

atenolol

25 mg daily or 50 mg daily

DRUG

placebo

one tablet daily

Trial Locations (1)

55455

University of Minnesota, Minneapolis

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

University of Minnesota

OTHER